Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas
- 30 September 1992
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 6 (3) , 157-162
- https://doi.org/10.1016/0268-960x(92)90027-n
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibodyCancer Immunology, Immunotherapy, 1991
- A humanized monovalent CD3 antibody which can activate homologous complementEuropean Journal of Immunology, 1991
- Immunotherapy of B lymphoma by anti-idiotype antibodies: Characterization of variant tumour cells appearing a long time after the initial tumour inoculationCancer Immunology, Immunotherapy, 1991
- Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cellsCancer Immunology, Immunotherapy, 1991
- Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survivalCancer, 1990
- Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal AntibodiesLeukemia & Lymphoma, 1990
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENTThe Lancet, 1982
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975